# 4GENE

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/4gene

- Industry: Consumer Products
- Headquarters: Germany
- Website: www.4gene.de
- Latest round: Seed (Jan 31, 2019)
- Investors on record: 4

## About

4GENE GmbH focuses on enhancing genetic research through its advanced genomic analysis tools, providing essential support for researchers and healthcare providers in understanding genetic conditions.Founded in 2017 in Germany, 4GENE GmbH specializes in genomic analysis technology. The company, led by CEO Heimo Adamski, raised an undisclosed amount of Seed funding in January 2019 from investors including Goldmann International GmbH, High-Tech Gründerfonds, MBG Baden-Wurttemberg, and Mittelstandische Beteiligungsgesellschaft Baden-Wurttemberg GmbH.4GENE offers a range of products and services aimed at enhancing genetic research and development. Their core product line includes advanced genomic analysis tools that facilitate the exploration of genetic data, aiding researchers and healthcare providers in understanding complex genetic conditions. These tools are designed for use in academic institutions, biotechnology firms, and healthcare organizations, primarily targeting markets in North America and Europe. The services provided encompass consulting and support for clients seeking to integrate genomic insights into their projects, such as personalized medicine, drug development, and genetic epidemiology.Revenue generation for 4GENE is primarily driven through a structured model involving direct sales of their genomic analysis tools and subscription-based services for ongoing support and updates. The company engages in business-to-business transactions, partnering with research institutions and healthcare providers that require specialized genomic services. Clients typically enter into agreements that include access to the software platform, with distinct pricing tiers based on the level of service and support required. Flagship products within this offering are expected to command premium pricing due to their advanced capabilities and the critical insights they provide to users.In the future, 4GENE plans to design and launch new genomic analysis tools to enhance its product offerings. Specific release dates are not currently available, but the company is actively pursuing expansion into North America and Europe to reach a broader customer base. The Seed funding raised in January 2019 will support these initiatives, allowing 4GENE to further develop its product line and enhance service offerings.

## Funding rounds

- Seed, Jan 31, 2019 — High-Tech Gruenderfonds, MBG Baden-Wuerttemberg, Goldmann International GmbH, Mittelstandische Beteiligungsgesellschaft Baden-Wurttemberg GmbH

## Investors

- High-Tech Gruenderfonds (https://capitalatlas.ai/funds/high-tech-gruenderfonds) — Seed
- MBG Baden-Wuerttemberg (https://capitalatlas.ai/funds/mbg-baden-wuerttemberg) — Seed
- Goldmann International GmbH — Seed
- Mittelstandische Beteiligungsgesellschaft Baden-Wurttemberg GmbH — Seed